Banka BioLoo's board has approved its consolidated financial results for the quarter ended June 30, 2025. The company posted a revenue from operations of Rs 11.14 Cr, reporting a marginal profit for the quarter. Key leadership re-appointments were also approved, including Mr. Sanjay Banka as Executive Chairman and Mr. Vishal Murarka as CEO for a three-year term, subject to shareholder approval at the upcoming Annual General Meeting (AGM). Dr. Basava Raju Dumpala was re-appointed as an Independent Director, and Mrs. Geeta Goti was appointed as a new Woman Independent Director. The 13th AGM is scheduled for September 10, 2025. Additionally, 9,900 ESOP shares were allotted, slightly increasing the paid-up capital.